Skip to main content
Livermore
Livermore
ZHEN

Lakefront Biotherapeutics NV

LKFT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001421876

No open-market purchases or sales by Lakefront Biotherapeutics NV insiders were filed in the last 90 days; 76 institutions reported holding it in 13F filings for Q2 2026, worth $960.3M in total; Greenlight Capital is the only superinvestor holding it.

Other share classesGLPGF

Q3 2021 vs. Q2 2021

How the institutions holding Lakefront Biotherapeutics NV changed between Q2 2021 and Q3 2021.

All holders in Q3 2021All holders in Q2 2021

13F holders of LKFT: Q2 2021 compared with Q3 2021
MeasureQ2 2021Of which not filed for Q3 2021Q3 2021Change
Holders109181−27
Shares7.51M88.55M+1.04M (+13.9%)
Value$517.2M$1.00K$449.8M−$67.4M (−13.0%)

1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (14)

Institutions that held Lakefront Biotherapeutics NV at the end of Q3 2021 but not at the end of Q2 2021.

Institutions new to LKFT in Q3 2021
InstitutionSharesValue% of portfolio
EcoR1 Capital, LLC1,558,749$82.0M2.90%
BVF Inc1,119,733$58.9M2.30%
Stonepine Capital Management, LLC244,205$12.8M5.85%
Sio Capital Management, LLC224,719$11.8M3.81%
Soleus Capital Management, L.P.115,300$6.07M0.95%
LMR Partners LLP100,000$5.26M0.07%
HAP Trading, LLC28,579$1.50M0.11%
ExodusPoint Capital Management, LP20,078$1.06M0.02%
PointState Capital LP17,500$921.0K0.02%
Two Sigma Advisers, LP15,100$794.0K0.00%
Bluefin Capital Management, LLC13,740$723.0K0.08%
Continental Advisors LLC10,000$526.0K0.38%
CSS LLC5,764$303.0K0.02%
Quantbot Technologies LP5,713$300.0K0.02%

Sold out (41)

Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2021 and filed for Q3 2021 without it.

Institutions that sold out of LKFT in Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
Capital International Investors1,731,410$119.3M
Deerfield Management Company, L.P. (Series C)657,005$45.3M
Rock Springs Capital Management LP165,000$11.4M
Aquilo Capital Management, LLC142,340$9.81M
Ghost Tree Capital, LLC75,000$5.17M
Caption Management, LLC56,800$3.91M
Ghisallo Capital Management LLC48,731$3.36M
Schonfeld Strategic Advisors LLC42,510$2.93M
HealthCor Management, L.P.41,080$2.83M
Henry James International Management, Inc.35,137$2.42M
Caas Capital Management LP32,869$2.26M
Parametric Portfolio Associates LLC19,510$1.34M
Balyasny Asset Management LLC18,020$1.24M
Nomura Asset Management Co Ltd17,200$1.18M
Highland Capital Management Fund Advisors, L.P.14,000$964.0K
Envestnet Asset Management Inc13,449$927.0K
Ergoteles LLC12,268$845.0K
Northern Trust Corp6,300$435.0K
Capital Asset Advisory Services LLC5,561$383.0K
Aigen Investment Management, LP4,963$342.0K
Trexquant Investment LP3,939$271.0K
American National Insurance Co3,500$241.0K
Moody National Bank Trust Division3,500$241.0K
Credit Agricole S A3,400$234.0K
Comerica Bank3,717$210.0K
FORA Capital, LLC1,360$94.0K
Deutsche Bank AG1,040$72.0K
Advisory Services Network, LLC1,050$72.0K
Proequities, Inc.686$47.0K
The PNC Financial Services Group, Inc.167$11.0K
Zions Bancorporation, N.A.94$6.00K
Ellevest, Inc.45$3.00K
Enterprise Financial Services Corp28$2.00K
Accel Wealth Management22$2.00K
Eaton Vance Management21$1.00K
Column Capital Advisors, LLC19$1.00K
Berman Capital Advisors, LLC22$1.00K
First Horizon Advisors, Inc.9$0
Glassman Wealth Services4$0
Rockefeller Capital Management L.P.5$0
State of Wyoming1$0

Not filed for Q3 2021 yet (1)

Institutions that held Lakefront Biotherapeutics NV at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LKFT in Q2 2021 that haven't filed for Q3 2021
InstitutionShares, Q2 2021Value, Q2 2021
CWM, LLC8$1.00K